Global Prior Art (GPA) Expands Its MedTech Efforts to Defeat Growing Patent Troll Threats in the Medical Device Technology Sector
Global Prior Art (GPA) is pleased to announce we will leverage our unrivalled expertise in the Medical Device Space to extend our efforts deterring NPE threats facing the Med Tech sector. Innovative medical technologies often integrate technologies from other sectors—AI, software, imaging, communication, and security—making them extremely vulnerable to attacks from multiple NPEs with costly demands.
Global’s new MedTech focused service leverages our deterrence model, widely recognized as yielding the highest success rate uncovering invalidating prior art. Building on 40 years’ of medical device experience to the job of finding the invalidating prior art that neutralizes NPE patents quickly and cost-effectively.
Why GPA’s Medical Device Team Is Different
Deep, hands-on domain expertise: A U.S.-based team of experts having deep knowledge across the scope of Medical Technologies, including AI-based diagnostics; surgical robotics; catheter-based therapies; implantable cardiovascular devices; wearable diabetes devices; minimally invasive surgical, orthopedic, cardiovascular, neurosurgical, and neurovascular procedures; delivery devices for cell-based therapies, and others.
Knowledge where the art is: The strongest invalidity art in MedTech often isn’t in a patent database. We have extensive experience finding non-patent literature worldwide, including academic journals, conference proceedings, clinical and regulatory materials, and product literature.
Knowing the history and evolution of the technology: Familiarity with details, i.e., institutions, companies, and inventors behind the medical device technologies. GPA’s long term IP experience allows the MedTech Experts to trace the evolution of key medical device technologies, key technology developments at the time and find key pieces of prior art in the immediate or analogous field that keyword searches usually miss.
Cross-disciplinary depth for converged devices: When an NPE patent targets the software, electronics, or communications layer of a device, our medical device analysts work alongside GPA’s experts in Electronics, Telecom, Mechanical, Software/AI technologies, Chemistry, Biotech, and pharma teams. Every element of the claim gets examined by the right expert.
Built around the claims that matter. Years of close work with senior IP attorneys shape how we search. We identify the key claim limitations up front and build our search strategy around them, so our results are aimed at the arguments that decide cases.
Proactive Protection, Tailored to Your Portfolio
To proactively address threats against medical device companies, GPA will provide customized support for individuals and companies, along with member firms using our platform to identify NPE threats and set priorities on which patents to challenge.
Global’s new MedTech service includes a collection of proactive IP services that have allowed Global’s clients to identify and capture critical opportunities while identifying market threats. Patent quality is not a mantra, but a result of a disciplined process giving our clients a big industry advantage.
Get Started
For additional information or to sign up for the MedTech Services or Customized support please reach out to:
Lydia Bakalova, Medical Device Group Leader: [email protected]
Tanner Knabe, Medical Device Group Manager: [email protected]
Dr. Steven Miller, Medical Device Group Senior Advisor: [email protected]